🔎 Trials Near Me

Nyumbani › Skleroderma Diffuse › Illinois › Chicago

Majaribio ya kliniki ya Skleroderma Diffuse katika Chicago, IL

Masomo 7 ya Skleroderma Diffuse yanatafuta washiriki katika vituo vya Chicago na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

InaajiriHatua 2
  • University of Chicago Hospitals, Chicago
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT06470048

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

InaajiriHatua 1
  • The University of Chicago Medical Center, Chicago
Umri 18 hadi 74 · Jinsia zote · Imesasishwa 10 Sep 2026 · NCT07085104

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

InaajiriHatua 2/3
  • GSK Investigational Site, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT05878717

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

InaajiriHatua 1
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 28 Ago 2026 · NCT06925542

Platform Clinical Study for Conquering Scleroderma

InaajiriHatua 2
  • The University of Chicago Medical Center (UCMC), Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Ago 2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

InaajiriHatua 2/3
  • Northwestern Memorial Hospital, Chicago
  • The University of Chicago Medical Center, Chicago
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 17 Ago 2026 · NCT06328777

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

InaajiriHatua 1/2
  • Nkarta Investigational Site, Chicago
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 7 Ago 2026 · NCT06733935

Majaribio ya Skleroderma Diffuse katika miji mingine

Masomo mengine katika Chicago

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.